MRPL46 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 2.95350410794981E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.29819999195036E-09 |
Normal-vs-Stage2 |
7.353300E-04 |
Normal-vs-Stage3 |
1.21769999639199E-08 |
Normal-vs-Stage4 |
4.73639999998277E-07 |
Stage1-vs-Stage2 |
9.360600E-01 |
Stage1-vs-Stage3 |
5.788100E-02 |
Stage1-vs-Stage4 |
2.700600E-01 |
Stage2-vs-Stage3 |
1.901620E-01 |
Stage2-vs-Stage4 |
3.656600E-01 |
Stage3-vs-Stage4 |
8.887200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.95510282910527E-11 |
Normal-vs-AfricanAmerican |
3.21469999953194E-07 |
Normal-vs-Asian |
3.073800E-02 |
Caucasian-vs-AfricanAmerican |
3.722000E-01 |
Caucasian-vs-Asian |
4.403000E-01 |
AfricanAmerican-vs-Asian |
2.236400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.42930112190243E-11 |
Normal-vs-Female |
3.10359999922127E-08 |
Male-vs-Female |
4.423600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
4.94030000242063E-08 |
Normal-vs-Extreme_Weight |
1.40889966360191E-10 |
Normal-vs-Obese |
1.50629997364149E-09 |
Normal-vs-Extreme_Obese |
1.998780E-01 |
Normal_Weight-vs-Extreme_Weight |
9.721600E-01 |
Normal_Weight-vs-Obese |
8.307600E-01 |
Normal_Weight-vs-Extreme_Obese |
2.275800E-01 |
Extreme_Weight-vs-Obese |
8.255400E-01 |
Extreme_Weight-vs-Extreme_Obese |
3.451800E-01 |
Obese-vs-Extreme_Obese |
1.804810E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.980300E-03 |
Normal-vs-Age(41-60Yrs) |
2.26090257626765E-11 |
Normal-vs-Age(61-80Yrs) |
9.15090003772434E-10 |
Normal-vs-Age(81-100Yrs) |
4.30500000003775E-06 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.000200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.596000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.866600E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.498000E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.930800E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.697600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
2.76380029973211E-10 |
Normal-VS-Type2 PRCC |
4.47559999949831E-07 |
Normal-VS-KIRP CIMP |
2.16509998818282E-09 |
Normal-VS-Unclassified PRCC |
1.7985002376264E-10 |
Type1 PRCC-VS-Type2 PRCC |
6.613800E-01 |
Type1 PRCC-VS-KIRP CIMP |
6.424300E-03 |
Type1 PRCC-VS-Unclassified PRCC |
4.496200E-02 |
Type2 PRCC-VS-KIRP CIMP |
1.520470E-02 |
Type2 PRCC-VS-Unclassified PRCC |
3.355600E-02 |
KIRP CIMP-VS-Unclassified PRCC |
9.724400E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.34679997657139E-09 |
Normal-vs-N1 |
4.42429999969463E-07 |
Normal-vs-N2 |
1.17300000046505E-07 |
N0-vs-N1 |
5.927600E-01 |
N0-vs-N2 |
1.000620E-01 |
N1-vs-N2 |
1.489620E-01 |
|
|